乳腺癌：基础与临床的转化
作者： 邵志敏，沈镇宙 主编
出版社：上海交通大学出版社 2016年09月
简介： 邵志敏教授，首批教育部长江学者特聘教授，复旦大学特聘教授。现任复旦大学肿瘤研究所长、乳腺癌研究所所长，大外科主任兼乳腺外科主任，中国抗癌协会乳腺癌专业委员会名誉主任委员，中华医学会肿瘤学分会副主任委员，上海市抗癌协会乳腺癌专业委员会名誉主任委员，上海市医学会肿瘤专科委员会主任委员，第八届亚洲乳腺癌协会主席、St.Gallen乳腺癌大会专家团成员。主要从事乳腺癌的临床和基础研究，建立适合中国人群的早期筛查和诊疗流程，开展临床试验提高乳腺癌患者的预后，科研重点为乳腺癌的转化研究和乳腺癌转移机制研究等。已发表有关乳腺癌研究的论著近350篇，其中SCI收录100余篇，被世界医学文献引用逾3 000次，主编专著4本。多次荣获卫生部科技进步一等奖，上海市科技进步一、二、三等奖，国家科技进步二等奖，教育部科技进步一、二等奖项。由其领衔的团队分别入选教育部创新团队、上海市乳腺肿瘤重点实验室及上海市教委“重中之重临床医学中心B类”项目、上海市重要疾病联合攻关项目。先后主持国家杰出青年科研基金、国家自然科学基金、国家“十五”攻关课题、卫生部临床重点项目、“211”工程II、“985”项目、“973”课题及其他省部级项目30余项。 INTRODUCTION Pro. Shao Zhimin, distinguished professor of Fudan University, is one of the first batch of distinguished professor of Chang Jiang Scholars. He presently serves as the director of Fudan University Cancer Institute and Breast Cancer Institute; chairman of department of surgery and department of breast surgery in Fudan University Cancer Hospital; Honorary chairman of Breast Cancer Society, China Anti-Cancer Association; Vice chairman of oncology branch committee, Chinese Medical Association; Honorary chairman of Breast Cancer Society, Shanghai Anti-Cancer Association; Chairman of oncology branch committee, Shanghai Medical Association; Chairman of the Eighth Asian Breast Cancer Society, and member of the St. Gallen international breast cancer consensus panel. Prof.Shao engages in clinical and basic research for breast cancer. He established an early screening and diagnosis process for the Chinese population, and carry out clinical trials to improve the prognosis of breast cancer patients. His researches mainly focus on s breast cancer translational research and mechanisms of metastasis of breast cancer. He has published nearly 350 papers about breast cancer research, and over 100 of which is included by SCI and has been cited for more than 3000 times by the world’s medical literature. He also published four books about breast disease. Dr.Shao has been awarded with Prize of Science and Technology Progress of Ministry of Health, Grade I; Prize of Science and Technology Progress of Shanghai Government, Grade I, II and III; National Prize Prize of Science and Technology Progress, Grade II; and Prize of Science and Technology Progress of Ministry of Education, Grade I, II. He was chosen as leader of selected innovative team of the Ministry of Education, Shanghai Key Laboratory of Breast Malignancy Tumor, Shanghai Education Commission Type B Program of the Priority Project of Clinical Medical Centers, and the Shanghai Joint Research Project of Major Diseases. He hosted and actualized in over 30 key research projects including National Excellent Youth Foundation, National Science Foundation, Key Project of National 10th 5-year Plan, Priority project on clinical medicine of Ministry of Health, “211” Project phase II, “985” Project, “973” Project, and other provincial or ministerial projects.
